Celcuity Quarterly Income Statement
NASDAQ: CELCHealth CareMedical SpecialitiesUSD
67.94+0.07 (+0.10%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Celcuity revenue and earnings
Celcuity reported a net loss of $78.9 million, compared with a loss of $45.3 million a year earlier. Diluted earnings per share came in at -$1.44.
Summary generated from market data by MetaCap's automated system. Methodology
Celcuity income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 66.12M | 50.51M | 49.20M | 42.85M | 44.01M | 36.13M | 36.43M | 30.06M | 24.28M | 22.49M | 19.73M | 18.90M |
| Research & Development | 31.08M | 33.06M | 37.63M | 34.91M | 36.41M | 29.76M | 33.47M | 27.59M | 22.50M | 20.65M | 18.08M | 17.49M |
| Selling, General & Admin | 35.04M | 17.44M | — | — | 7.59M | 6.37M | — | — | — | — | — | — |
| Operating Income | -66.12M | -50.51M | -49.20M | -42.85M | -44.01M | -36.13M | -36.43M | -30.06M | -24.28M | -22.49M | -19.73M | -18.90M |
| Interest Expense | 5.42M | 6.08M | 6.17M | 4.59M | 3.20M | 3.18M | 3.27M | 3.34M | 2.26M | 1.40M | 1.40M | 1.37M |
| Other Income (Expense) | -12.75M | -2.33M | -1.77M | -955.00K | -1.26M | -864.00K | -223.00K | 268.00K | 562.00K | 881.00K | 880.80K | 493.50K |
| Pretax Income | -78.86M | -52.84M | -50.97M | -43.80M | -45.27M | -37.00M | -36.65M | -29.79M | -23.72M | -21.61M | -18.85M | -18.40M |
| Net Income | -78.86M | -52.84M | -50.97M | -43.80M | -45.27M | -37.00M | -36.65M | -29.79M | -23.72M | -21.61M | -18.85M | -18.40M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -1.44 | -0.97 | -0.97 | -0.92 | -1.04 | -0.86 | -0.87 | -0.70 | -0.62 | -0.64 | -0.65 | -0.83 |
| EPS (Diluted) | -1.44 | -0.97 | -0.97 | -0.92 | -1.04 | -0.86 | -0.87 | -0.70 | -0.62 | -0.64 | -0.65 | -0.83 |
| Shares Outstanding (Basic) | 54.82M | 54.46M | — | 47.59M | 43.66M | 43.05M | — | 42.79M | 38.44M | 33.61M | — | 22.12M |
| Shares Outstanding (Diluted) | 54.82M | 54.46M | — | 47.59M | 43.66M | 43.05M | — | 42.79M | 38.44M | 33.61M | — | 22.12M |
| EBITDA | -66.06M | -50.46M | -49.15M | -42.81M | -43.97M | -36.10M | -36.40M | -30.03M | -24.25M | -22.46M | -19.70M | -18.86M |
This table shows 12 quarterly periods of Celcuity's income statement, from Q2 2026 back to Q3 2023, across 14 line items including operating expenses, research & development, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow CELC's reporting calendar. What is a income statement?